treetta has started its activity with the aim of innovation in health, especially wound healing, since October 2015.
Relying on its researchers’ knowledge and after 8 years of cutting-edge technological research, it managed to design and produce wound dressings with a skin-similar structure. Given the company's special mission in treating patients, offering high-quality products is inevitable and a core mission for the company.
In order to achieve this goal, treetta Company performs its activities under the supervision of the Quality Management System including ISO 9001, ISO 13485, GMP and FDA QSR 21 CFR 820 (cGMP). After analyzing several examples of domestic and foreign wound dressings, as well as conducting extensive researches and clinical studies on acute/chronic ulcers, wound diseases and wound healing agents, treetta developed its advanced formulation in Iran for the first time. The invention was released in September 2015. The company is honored to receive the title of the National Institute of Elite Selected Inventions and to be approved by the Industrial Research Organization of Iran. Today, after broad researches and studies in this field, treetta Company has taken steps to introduce Advanced Wound Care Products with the treetta brand.